Table 2.

Baseline characteristics of subcohorts at time of BI initiation

	BI only	BI + 1 OAD	BI + 2 OADs	BI + ≥3 OADs	Total
Patients, n (%)	1319 (20)	2658 (40)	2024 (31)	596 (9)	6597 (100)
Female, %	50	48	44	38	46
Mean ± SD age, years	64.5 ± 12.5	61.6 ± 13.1	60.8 ± 12.4	61.3 ± 11.5	61.9 ± 12.7
Mean ± SD HbA1c at BI initiation, %	8.7 ± 2.0	9.3 ± 2.2	9.3 ± 2.0	9.1 ± 2.0	9.1a ± 2.1
Mean ± SD BMI at BI initiation, kg/m2	33.2 ± 7.8	33.5 ± 7.6	33.8 ± 7.6	33.8 ± 7.3	33.6 ± 7.6

BI basal insulin, BMI body mass index, HbA1c glycated hemoglobin, OAD oral antidiabetic, SD standard deviation

^aAt baseline, 3219 (48.8%) of the 6597 patients had an HbA1c > 9.0%